For its report, As You Sow evaluated CEO pay at S&P 500 companies. The nonprofit used data to compute what CEO pay would be assuming such pay is related to cumulative shareholder return. In its methodology, a ranking of companies by excess CEO pay and by shareholder votes on CEO pay are each weighted at 40 percent. The final ranking based on CEO-to-worker pay ratio is weighted at 20 percent.
As You Sow notes some CEOs may no longer hold the positions listed below, as the rankings were calculated using data made available before June 30, 2021.
Here are the five most overpaid healthcare CEOs, according to As You Sow:
Leonard Schleifer, MD, PhD (Regeneron Pharmaceuticals)
Pay: $135.35 million
CEO-to-worker pay ratio: 933:1
Excess pay: $121.68 million
Javier Rodriguez (DaVita)
Pay: $73.43 million
CEO-to-worker pay ratio: 1,137:1
Excess pay: $59.8 million
Alex Gorsky (Johnson & Johnson)
Pay: $29.58 million
CEO-to-worker pay ratio: 365:1
Excess pay: $15.95 million
Michael Neidorff (Centene)
Pay: $24.96 million
CEO-to-worker pay ratio: 362:1
Excess pay: $10.94 million
Ari Bousbib (IQVIA Holdings)
Pay: $25.58 million
CEO-to-worker pay ratio: 266:1
Excess pay: $10.64 million
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
